FDA Reverses Course On Convalescent Plasma Treatment For COVID-19
FDA Reverses Course On Convalescent Plasma Treatment For COVID-19

President Trump applauded the agency's emergency authorization during his press conference on Sunday.

CBS2's Ali Bauman reports